Mohit Kaushal insider trades: Oncology Institute (TOI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mohit reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | TOI | ↓ Sell | 95,719 | $3.50 | $335K | Direct | Apr 16, 2026 (0d) |
| Nov 14, 2022 | TOI | ↓ Sell | 15,994 | $2.13 | $34K | Direct | Nov 15, 2022 (1d) |
| Oct 24, 2022 | TOI | ↓ Sell | 4,798 | $4.96 | $24K | Direct | Oct 25, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TOI insiders
Open-market trades in the last 12 months
About Mohit Kaushal's insider trades
Mohit Kaushal is a director at Oncology Institute (TOI). Since Oct 24, 2022, Mohit has reported no open-market purchases and 3 sales worth $393K on SEC Form 4. In the last 12 months: 1 sale ($335K).
Their filings also include grants and awards (12 filings), shares returned to the company (3 filings), other transactions (3 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TOI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.